Linden Advisors’s Precigen PGEN Stock Holding History

Linden Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-241,534	Closed	-$1.67M	–	836
2021 Q1	$1.67M	Hold	241,534	–	–	0.01%	459
2020 Q4	$2.46M	Buy	241,534 +151,370	+168%	+$981K	0.02%	304
2020 Q3	$316K	Hold	90,164	–	–	﹤0.01%	287
2020 Q2	$450K	Hold	90,164	–	–	0.01%	216
2020 Q1	$306K	Hold	90,164	–	–	0.01%	194
2019 Q4	$494K	Hold	90,164	–	–	0.01%	196
2019 Q3	$516K	Hold	90,164	–	–	0.01%	175
2019 Q2	$691K	Buy	+90,164	New	+$485K	0.01%	159

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Linden Advisors's PGEN Position: Q2 2021 in Review

Linden Advisors sold out of Precigen (PGEN) in Q2 2021, closing a stake of 241,534 shares — an estimated $1.67M sold.

Linden Advisors first reported a position in PGEN in Q2 2019 and held it in 8 quarters. The position peaked at $2.46M in Q4 2020. 150 funds tracked by Wall St. Rank hold PGEN as of Q2 2021.

Linden Advisors reported no remaining Precigen position as of Q2 2021 after selling out during the quarter.
Linden Advisors sold 241,534 Precigen shares in Q2 2021, an estimated $1.67M.
Linden Advisors first reported a position in Precigen in Q2 2019 and held it in 8 quarters.
Linden Advisors's Precigen position peaked at $2.46M in Q4 2020.
150 funds tracked by Wall St. Rank held Precigen as of Q2 2021.

Based on Linden Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.